tissue-based diagnostics | GenomeWeb

tissue-based diagnostics

Molecular Autopsy Consortium of Houston members outlined their recommendations for using molecular autopsy to investigate unexplained deaths in young people. 

While the deal has provided AstraZeneca and MedImmune access to the tissue phenomics technology, Definiens now has broader and clearer access to patients.


Roche Diagnostics announced today it has purchased a technology portfolio for microdissection of slide-mounted tissue sections from AvanSci Bio.

NEW YORK (GenomeWeb) – Definiens announced today that it has raised €15 million ($20.4 million) in a private round of financing that will support the firm's efforts to expand its business into digital tissue diagnostics.

NEW YORK (GenomeWeb News) – The Translational Genomics Research Institute has struck a collaborative research agreement with Ventana Medical Systems to study new biomarkers for use in treating pancreatic cancer, Ventana said today.

NEW YORK (GenomeWeb News) – Leica Biosystems and Synthon Biopharmaceuticals announced today a collaboration to develop and commercialize companion diagnostics for drugs aimed at treating solid tumors.

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared for marketing Applied Spectral Imaging's GenASIs Scan & Analysis automated gene scanner as an aid in ALK gene analysis for lung cancer therapy selection, ASI said this week.

NEW YORK (GenomeWeb News) – Agilent Technologies company Dako today announced a companion diagnostic agreement with Pfizer.
The deal establishes a legal framework for the two firms to carry out R&D and commercialization work as well as advisory services, Dako said.

NEW YORK (GenomeWeb News) – Through eight months ending May 31, 2012, Dako posted $242 million in revenues, Agilent Technologies disclosed in a regulatory filing after the close of the market on Wednesday, which also disclosed Dako's earnings for full-year 2011 and for the six months ended March

The story has been updated to include comments from a conference call.
NEW YORK (GenomeWeb News) – Agilent Technologies and Swedish private equity firm EQT today announced that Agilent will acquire cancer diagnostics firm Dako from EQT for $2.2 billion.


Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.